Antacid Comparison Chart

Description Action Neutralizing effect Protective effect

Aluminum hydroxide is an amorphous form of aluminum Aluminum hydroxide is a typical antacid active, very often Aluminum hydroxide in which there is a partial substitution of combined with magnesium hydroxide. Aluminum hydroxide Hydroxide Gels carbonate for hydroxide. On dry basis, it contains the as an antacid is not exactly an aluminum hydroxide (Al(OH)3), equivalent of NLT 76.5% of Al(OH)3, and it may contain it is an aluminum « hydroxy-carbonate » (Al(OH)3-2x (CO3)x, & Powders varying quantities of basic aluminum carbonate and with x within 0.1 to 0.4 where some hydroxides (OH-) are bicarbonate. substituted by carbonates (CO32-). It has an amorphous structure. It is this amorphous structure which allows the acid neutralizing capacity. Side effects: Constipating. Can chelate dietary phosphate, so can potentially deplete phosphate from the stomach.

On dry basis magnesium hydroxide, dried at 105°C for Magnesium hydroxide as aluminum hydroxide is a typical Magnesium 2 hours, contains not less than 95.0% and not more antacid active. Both are often combined, offering a good than 100.5% of Mg(OH)2. neutralizing and pH buffering effect and compensating their Hydroxide Gels side effects. It is also used as laxative active (Milk of Magnesia). & Powders Magnesium hydroxide has a crystalline structure.

On dry basis calcium carbonate, dried at 200°C for Calcium carbonate is a very reactive antacid active which is Calcium 4 hours, contains not less than 98.5% and not more used alone or in combination with magnesium compounds. Carbonate than 100.5% of CaCO3. It has a crystalline structure and buffering properties. Powders

Magaldrate is a chemical combination of aluminum Magaldrate is a basic aluminum and magnesium compound Magaldrate and magnesium hydroxides and sulphate, possessing a layer structure connected by water and sulphate corresponding to the formula: Al5Mg10(OH)31(SO4)2·xH2O. bridges and is crystalline by nature. This unique crystal lattice Gels & It contains the equivalent of not less than 90.0% structure results in the high reactivity for magaldrate. The

Powders and not more than 105.0% of Al5Mg10(OH)31(SO4)2, antacid effectiveness of magaldrate can be used to treat peptic calculated on the dried basis. ulcers because it neutralizes gastric acid very quickly while buffering the pH even in presence of proteins and pepsin. Magaldrate can also absorb large quantities of bile acids which prevent these acids from attacking the mucous membranes.

Aluminum phosphate gel is a suspension of hydrated Aluminum phosphate (AlPO4) functions by coating the stomach Aluminum AlPO4. Content: 19.0% to 21.0% of AlPO4. wall. It does not neutralize stomach acids. Aluminum phosphate absorbs the bile acids and stomach gas. Since the product does Phosphate not chelate dietary phosphate, it does not deplete phosphate Gel from the stomach.

Boehmite gel is a white or almost white, translucent, Boehmite is a crystalline form of aluminum hydroxide. Unlike viscous, colloidal gel of aluminum oxide hydroxide: the amorphous form of aluminum hydroxide gel, boehmite

[AlO(OH)]1,nH2O. does not dissolve in hydrochloric acid (HCl). Boehmite protects Boehmite Gel the stomach wall by absorbing stomach acid and creating a “high viscosity gel.” It is chosen primarily because of its lower aluminum solubility. The product, by design, has lower acid neutralizing capacity (ANC) compared to standard aluminum hydroxide gel.

www.spipharma.com www.spipharma.com

Americas Europe/Middle East/ Africa Asia/Pacific Australia Distribution Company SPI Pharma, Inc. SPI Pharma SAS SPI Pharma, Inc – India Branch Anzchem Rockwood Office Park Chemin du Vallon du Maire 21 B, Veerasandra Industrial Area 1 Braidwood Street 503 Carr Rd., Suite 210 13240 Septemes-Les Vallons Hosur Road, Bangalore – 560100 Enfield NSW 2136 Wilmington, DE 19809 France Karnataka, India Australia

T 302 576 8600 T 33 4 9196 3600 T 91 80 3027 0005 T 61 2 9475 2200 SPI-AA-ALL-6000-01201500 800 789 9755 Ext. 8600 F 33 4 9196 3633 F 91 80 3027 0050 F 61 2 9475 2211 01-2015 | All rights reserved F 302 576 8567

© SPI Pharma 2015. All trademarks are the property of SPI Pharma. The information contained in this document is proprietary to SPI Pharma unless otherwise noted and may not be used or disseminated inappropriately. The information and recommendations contained herein are to the best of SPI Pharma, Inc.’s knowledge reliable and accurate. Any recommendations are made without warranty, either implied or expressed, due to the variations in equipment, conditions, and methods which may be used in commercially processing the products. No warranties of any kind are made, express or implied, including those of merchantability and fitness for particular purpose, other than the products conform to current standard specifications. SPI Pharma, Inc. makes no warranty that the use of the products or formulations provided by SPI Pharma, Inc. will not infringe any trademark, trade name, copyright, patent or other rights held by any third party when used in customer’s application. SPI Pharma, Inc. shall not be liable for loss of profit or for incidental, special or consequential loss or damages.